SCHEMBL29516468

SCHEMBL29516468

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ EDNRA P25101 1/20 0.61
▸ KISS1R Q969F8 11/20 0.54
▸ MAGI3 Q5TCQ9 1/20 0.53
▸ ECE1 P42892 3/20 0.53
▸ ERAP2 Q6P179 1/20 0.52
▸ PCSK9 Q8NBP7 2/20 0.52
▸ ACE P12821 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30465868 0.85 ECE1 (0.59) EDNRAKISS1RECE1ERAP2ACE
SCHEMBL29619341 0.84 MAGI3 (0.59) EDNRAMAGI3ECE1ERAP2ACE
SCHEMBL30093046 0.84 EDNRA (0.69) EDNRAECE1ERAP2ACE
SCHEMBL30533184 0.84 EDNRA (0.76) EDNRAECE1ERAP2ACE
SCHEMBL30660136 0.84 EDNRA (0.58) EDNRAMAGI3ECE1ERAP2ACE
SCHEMBL30465910 0.84 ECE1 (0.60) MAGI3ECE1ERAP2ACE
SCHEMBL29619347 0.83 MAGI3 (0.60) EDNRAMAGI3ECE1ERAP2ACE
SCHEMBL31073535 0.83 ECE1 (0.60) KISS1RECE1ERAP2ACE
SCHEMBL30310827 0.83 ACE (0.62) EDNRAECE1ACE
SCHEMBL7261791 0.83 EDNRA (0.65) EDNRAECE1ERAP2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115478875-B Up-line repeated mining subarea grouting method for downward caving type residual mining area 山西焦煤集团有限责任公司 2025-04-08 — — CN claimed
CN-118979116-A Anthrax, plague and bubbly triple RPA detection kit, primer probe composition and application 中国人民解放军军事科学院军事医学研究院 2024-11-19 — — CN claimed
CN-118508832-A Inductive ripple voltage suppression method based on low-pass filter circuit 东南大学 2024-08-16 — — CN claimed
CN-118171468-A Double-layer MoS realized by constructing substrate steps2Method for stacking controlled growth 东南大学 2024-06-11 — — CN claimed
US-12000937-B2 Convenient monitoring method and system for swing collapse risk of skyscrapers GUANGDONG UNIVERSITY OF PETROCHEMICAL TECHNOLOGY (CN) 2024-06-04 — — US claimed
CN-117432242-A In-situ demolition construction method for underground cavity structure 中建三局集团有限公司 2024-01-23 — — CN claimed
CN-116484313-A Multi-source meteorological data fusion method based on optimal interpolation method 国网江苏省电力有限公司盐城供电分公司 2023-07-25 — — CN claimed
US-20230194732-A1 CONVENIENT MONITORING METHOD AND SYSTEM FOR SWING COLLAPSE RISK OF SKYSCRAPERS GUANGDONG UNIVERSITY OF PETROCHEMICAL TECHNOLOGY (CN) 2023-06-22 — — US claimed
CN-115478875-A Down-collapse type residual mining area ascending re-mining subarea grouting method 山西焦煤集团有限责任公司 2022-12-16 — — CN claimed
CN-114252005-A Portable swing monitoring method and device for skyscraper building 广东石油化工学院 2022-03-29 — — CN claimed
EP-4462436-B1 MULTIPLEX DROP-OFF DIGITAL POLYMERASE CHAIN REACTION METHODS STILLA TECH (FR) 2026-05-13 — — EP disclosed
EP-4736921-A2 RESPIRATORY PRESSURE THERAPY DEVICE ResMed Pty Ltd (AU) 2026-05-06 — — EP disclosed
US-20260121837-A1 DATA ENCRYPTION AND DECRYPTION USING SKIP BITS AND VARIABLE XOR QUANTITY CERULEANT SYSTEMS LLC (US) 2026-04-30 — — US disclosed
EP-4549192-B1 ELECTRIC WORK VEHICLE KUBOTA KK (JP) 2026-04-29 — — EP disclosed
US-12611920-B2 Electric work vehicle KUBOTA CORPORATION (JP) 2026-04-28 — — US disclosed
CN-108495847-B Process for producing 2-hydrazinobenzothiazole derivatives DIC株式会社 2022-07-01 — — CN disclosed
US-11336914-B2 History-based candidate list with classification QUALCOMM INCORPORATED (US) 2022-05-17 — — US disclosed
WO-2022094655-A1 RESPIRATORY PRESSURE THERAPY DEVICE ResMed Pty Ltd (AU) 2022-05-12 — — WO disclosed
WO-2022069509-A1 2-(3-PYRIDIN-2-YL-4-QUINOLIN-4-YL-PYRAZOL-1-YL)-ACETAMIDE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA RECEPTOR I/ALK5 ORIGO BIOPHARMA, S.L. (ES) 2022-04-07 — — WO disclosed
CN-114252005-A Portable swing monitoring method and device for skyscraper building 广东石油化工学院 2022-03-29 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260121837-A1 DATA ENCRYPTION AND DECRYPTION USING SKIP BITS AND VARIABLE XOR QUANTITY FGR, NPY2R, FUBP1 EDNRA 1306/4885KISS1R 93/4885MAGI3 2180/4885
US-12611920-B2 Electric work vehicle DCX, SMN1; SMN2, MMP10 EDNRA 4270/4885KISS1R 4285/4885MAGI3 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback